Expression of resistin in the liver of patients with non-alcoholic fatty liver disease

Piotr Gierej; Beata Gierej; Piotr Kalinowski; Tadeusz Wróblewski; Rafał Paluszkiewicz; Konrad Kobryń; Bogna Ziarkiewicz-Wróblewska

doi:10.5114/pjp.2017.67583

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2017
vol. 68

Send email

Copy url:

abstract:

Original paper

Expression of resistin in the liver of patients with non-alcoholic fatty liver disease

Piotr Gierej

,

Beata Gierej

,

Piotr Kalinowski

,

Tadeusz Wróblewski

,

Rafał Paluszkiewicz

,

Konrad Kobryń

,

Bogna Ziarkiewicz-Wróblewska

Pol J Pathol 2017; 68 (3): 225-233

DOI: https://doi.org/10.5114/pjp.2017.67583

Online publish date: 2017/11/30

View full text Get citation

PlumX metrics:

Adipokines are cytokines that presumably connect the pathologies of metabolic syndrome. One of the adipokines is resistin, the role of which in insulin resistance, obesity, and non-alcoholic fatty liver disease (NAFLD) needs to be determined. Liver biopsy specimens were obtained intraoperatively from 214 obese patients. Histological assessment was based on NAFLD activity score according to Kleiner. Statistical analysis involved semi-quantitive immunohistochemistry assessment of resistin staining and: NAFLD status in obese patients compared with a non-obese control group, selected clinical data (age, sex, body mass index – BMI), selected biochemical data, comorbidities (hypertension, type 2 diabetes mellitus, dyslipidaemia), and metformin treatment in patients with type 2 diabetes mellitus. Resistin expression was observed in the histiocytes of inflammatory infiltrate, Kupffer cells, and histiocytes surrounding the hepatocytes with steatosis. There was a positive correlation between the total expression of resistin and: (1) NAFLD advancement (NAFLD Activity Score- NAS), (2) AST, ALT, BMI, glucose, insulin, Homeostasis Model Assessment (HOMA), LDH, GGT, triglycerides (TG), and glycated haemoglobin (HbA1c). Resistin expression was more intense in patients with type 2 diabetes mellitus and dyslipidaemia and less intense in the control group. Resistin probably plays a role in the pathogenesis of hepatic insulin resistance and aggravates pathologic changes in the liver of patients with NAFLD.

keywords:

Expression of resistin in the liver of patients with non-alcoholic fatty liver disease

Piotr Gierej , Beata Gierej , Piotr Kalinowski , Tadeusz Wróblewski , Rafał Paluszkiewicz , Konrad Kobryń , Bogna Ziarkiewicz-Wróblewska

adipokines, insulin resistance, steatohepatitis, obesity

Piotr Gierej

,

Beata Gierej

,

Piotr Kalinowski

,

Tadeusz Wróblewski

,

Rafał Paluszkiewicz

,

Konrad Kobryń

,

Bogna Ziarkiewicz-Wróblewska